0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessBoth asthma and chronic obstructive pulmonary disease (COPD) are characterized by airflow obstruction and chronic inflammation of the airways, but there are important differences in inflammatory mechanisms and response to therapy between these diseases [1, 2]. This chapter discusses the pharmacology of the drugs used in the treatment of obstructive airways diseases. These drugs include bronchodilators, which act mainly by reversing airway smooth muscle contraction and anti-inflammatory drugs, which in asthma suppress the inflammatory response in the airways. The most effective anti-inflammatory treatment for asthma is corticosteroids, which are covered in chapter C13. In COPD, no effective anti-inflammatory drugs are available, but several new classes of drug are now in development.
Peter J Barnes (2011). C4 Drugs for the treatment of airway diseaseDOI: https://doi.org/10.1007/978-3-0346-0136-8_19,
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Chapter in a book
Year
2011
Authors
1
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1007/978-3-0346-0136-8_19
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access